These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33754053)

  • 1. Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancer.
    Wan J; Huang L; Cheng J; Qi H; Jin J; Wang H
    Theranostics; 2021; 11(9):4137-4154. PubMed ID: 33754053
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-assembling poly(ethylene glycol)-block-polylactide-cabazitaxel conjugate nanoparticles for anticancer therapy with high efficacy and low in vivo toxicity.
    Shuai Q; Zhao G; Lian X; Wan J; Cen B; Zhang W; Liu J; Su W; Wang H
    Int J Pharm; 2020 Jan; 574():118879. PubMed ID: 31770581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of a Cabazitaxel Prodrug Using Nanoparticle Delivery for the Treatment of Taxane-Resistant Malignancies.
    Xie B; Wan J; Chen X; Han W; Wang H
    Mol Cancer Ther; 2020 Mar; 19(3):822-834. PubMed ID: 31848296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular nanoparticles self-assembled from reduction-responsive cabazitaxel prodrugs for effective cancer therapy.
    Jin J; Wan J; Hu X; Fang T; Ye Z; Wang H
    Chem Commun (Camb); 2021 Mar; 57(18):2261-2264. PubMed ID: 33532809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general prodrug nanohydrogel platform for reduction-triggered drug activation and treatment of taxane-resistant malignancies.
    Yao J; Li T; Shi X; Wang Y; Fang S; Wang H
    Acta Biomater; 2021 Aug; 130():409-422. PubMed ID: 34087447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity.
    Wang H; Lu Z; Wang L; Guo T; Wu J; Wan J; Zhou L; Li H; Li Z; Jiang D; Song P; Xie H; Zhou L; Xu X; Zheng S
    Cancer Res; 2017 Dec; 77(24):6963-6974. PubMed ID: 29055017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.
    Mao X; Si J; Huang Q; Sun X; Zhang Q; Shen Y; Tang J; Liu X; Sui M
    Adv Healthc Mater; 2016 Oct; 5(19):2517-2527. PubMed ID: 27529558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
    Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
    J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
    Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
    Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy.
    Sun Y; Zhao Y; Teng S; Hao F; Zhang H; Meng F; Zhao X; Zheng X; Bi Y; Yao Y; Lee RJ; Teng L
    Int J Nanomedicine; 2019; 14():135-148. PubMed ID: 30613142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A convenient protonated strategy for constructing nanodrugs from hydrophobic drug-inhibitor conjugates to reverse tumor multidrug resistance.
    Wang P; Wang Y; Xia X; Wu J; Lin J; Huang W; Yan D
    Nanoscale; 2024 May; 16(17):8434-8446. PubMed ID: 38592819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
    Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
    J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles.
    Cao ZT; Chen ZY; Sun CY; Li HJ; Wang HX; Cheng QQ; Zuo ZQ; Wang JL; Liu YZ; Wang YC; Wang J
    Biomaterials; 2016 Jul; 94():9-19. PubMed ID: 27088406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Serum Albumin Nanoparticles as a Novel Delivery System for Cabazitaxel.
    Zhou G; Jin X; Zhu P; Yao JU; Zhang Y; Teng L; Lee RJ; Zhang X; Hong W
    Anticancer Res; 2016 Apr; 36(4):1649-56. PubMed ID: 27069142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.